Clinical Trial Update: Evaluation of Intravaginal Gel and Ovule Formulations of TOL-463 [Phase 1]

View source ↗

Summary

Phase 1 evaluation of intravaginal gel and ovule formulations of TOL-463 for vaginal infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Infection

Drugs mentioned

• TOL-463

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Vaginal Infection | Phase 1 | Status: COMPLETED